Average Co-Inventor Count = 1.67
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Beth Israel Deaconess Medical Center, Inc. (11 from 516 patents)
2. Children's Medical Center Corporation (5 from 1,036 patents)
3. New England Deaconess Hospital Corporation (2 from 53 patents)
18 patents:
1. 6653283 - Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
2. 6489293 - Recombinant human erythropoietin with altered biological activity
3. 6403558 - Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
4. 6287777 - NPG-1 gene that is differentially expressed in prostate tumors
5. 6242570 - Production and use of recombinant protein multimers with increased biological activity
6. 6187564 - DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
7. 6177244 - NPG-1 gene that is differentially expressed in prostate tumors
8. 6153407 - Erythropoietin DNA having modified 5' and 3' sequences and its use to
9. 6107272 - Modified polypeptides with altered biological activity
10. 6048971 - Recombinant human erythropoietin mutants
11. 6025331 - Pharmaceutical compositions comprising troponin subunits, fragments and
12. 5919758 - Modified polypeptides with altered biological activity
13. 5837680 - Pharmaceutical compositions comprising troponin subunits, fragments and
14. 5804382 - Methods for identifying differentially expressed genes and differences
15. 5747446 - Modified polypeptides with increased biological activity